- Vetlen signs distribution agreement with Patterson Equine
- Expands access to the Vetlen Pouch for equine veterinarians
- Device delivers targeted, sustained antibiotic therapy at infection sites
- Designed for complex wounds and hard-to-treat infections
- Available nationwide through Patterson’s distribution network
Vetlen has announced a new distribution partnership with Patterson Equine aimed at increasing access to its Vetlen Pouch, a device designed to deliver targeted antibiotic therapy directly to infection sites in horses.
Expanding Access Through Distribution
Through the agreement, equine veterinarians across the U.S. will be able to order the Vetlen Pouch via Patterson Equine’s established distribution network and online platform.
The partnership is intended to simplify access to the device and support broader adoption in equine practice.
Targeted Approach to Infection Treatment
The Vetlen Pouch is designed to deliver antibiotics directly where they are needed, helping veterinarians manage complex infections more effectively.
It uses a passive delivery system that allows antibiotics to diffuse over time, eliminating the need for pumps or external power sources. The device can remain in place for up to 30 days, providing ongoing localized treatment.
Supporting Challenging Cases
The device is being used in both soft tissue and orthopedic cases, particularly where infections are difficult to treat or involve resistant bacteria.
Veterinarians can administer daily treatments through a catheter system, allowing for continued therapy without repeated invasive procedures.
Focus on Innovation in Equine Care
Vetlen, a veterinarian-founded company, is focused on developing practical, science-based tools to improve clinical outcomes.
By partnering with Patterson Equine—one of the largest veterinary distributors in the U.S.—the company aims to bring its technology to more equine practitioners and support improved care for horses nationwide.
Information sourced from the company’s press release.
